Key result
A dual chamber pacemaker programmed to DDD60 reduced syncope or symptomatic events compared with DDI30 in patients with bifascicular block.
Why the study?
Does permanent cardiac pacing programmed to DDD60 reduce syncope and symptomatic events in patients with bifascicular block and unexplained syncope compared to DDI30 backup pacing?
RCT (n=101)
single-blinded
randomized
Yes
Does permanent cardiac pacing programmed to DDD60 reduce syncope and symptomatic events in patients with bifascicular block and unexplained syncope compared to DDI30 backup pacing?
In patients with bifascicular block and unexplained syncope, permanent pacing programmed to DDD60 significantly reduces syncope and symptomatic events compared to backup DDI30 pacing.
Answers are grounded in this paper and cite their sources.
Supports DDD60 over DDI30 programming in bifascicular block with syncope; confirms benefit of active dual-chamber pacing in this population.
BACKGROUND: Syncope in patients with bifascicular block (BFB) is a common event whose causes might be difficult to assess. METHODS AND RESULTS: Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRESS) is a multicenter, prospective, randomized, single-blinded study designed to demonstrate a reduction in symptomatic events in patients with bifascicular block and syncope of undetermined origin implanted with permanent pacemaker. Device programming mode (NASPE/BPEG code) at DDD with a lower rate of 60 ppm is compared with backup pacing at DDI with a lower rate of 30 ppm. The end point consisted of (1) syncope, (2) symptomatic presyncopal episodes associated with a device intervention (ventricular pacing), and (3) symptomatic episodes associated with intermittent or permanent atrioventricular block (any degree). One hundred one patients were enrolled and randomized. Primary end point events at 2 years were observed in 23 patients, with a significant lower incidence in the study group (hazard ratio, 0.32; 95% confidence interval [CI], 0.10-0.96; P=0.042). Reduction of any symptoms, associated or not with device intervention, was superior in DDD60 compared with DDI30 (hazard ratio, 0.4; 95% confidence interval, 0.25-0.78; P=0.0053). Fourteen patients developed other rhythm diseases and met class I indication for pacing. The annual incidence of rhythm disease development was 7.4%. CONCLUSIONS: In patients with bifascicular block and syncope of undetermined origin, the use of a dual chamber pacemaker programmed to DDD60 led to a significant reduction of syncope or symptomatic events associated with a cardioinhibitory origin, compared with DDI30 programming. Symptoms associated with a new onset of rhythm disease were found in 15% of the population at 2 years.
No takes yet. Share an insight, caveat, or question.
Santini et al. (2013) conducted an RCT in Bifascicular block and syncope of undetermined origin (n=101). Dual chamber pacemaker programmed to DDD vs. Backup pacing at DDI with a lower rate of 30 ppm was evaluated on Syncope, symptomatic presyncopal episodes associated with device intervention, and symptomatic episodes associated with intermittent or permanent atrioventricular block (HR 0.32, 95% CI 0.10-0.96, p=0.042). A dual chamber pacemaker programmed to DDD60 reduced syncope or symptomatic events compared with DDI30 in patients with bifascicular block.
Synapse has enriched 10 related papers. Consider them for comparative context: